Select Equity Group’s BioLife Solutions BLFS Stock Holding History

Select Equity Group’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,688	Closed	-$227K	–	156
2020 Q4	$227K	Sell	5,688 -9,769	-63%	-$333K	﹤0.01%	136
2020 Q3	$447K	Sell	15,457 -406	-3%	-$8.77K	﹤0.01%	128
2020 Q2	$259K	Buy	+15,863	New	+$219K	﹤0.01%	140

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Select Equity Group's BLFS Position: Q1 2021 in Review

Select Equity Group sold out of BioLife Solutions (BLFS) in Q1 2021, closing a stake of 5,688 shares — an estimated $227K sold.

Select Equity Group first reported a position in BLFS in Q2 2020 and held it in 3 quarters. The position peaked at $447K in Q3 2020. 132 funds tracked by Wall St. Rank hold BLFS as of Q1 2021.

Select Equity Group reported no remaining BioLife Solutions position as of Q1 2021 after selling out during the quarter.
Select Equity Group sold 5,688 BioLife Solutions shares in Q1 2021, an estimated $227K.
Select Equity Group first reported a position in BioLife Solutions in Q2 2020 and held it in 3 quarters.
Select Equity Group's BioLife Solutions position peaked at $447K in Q3 2020.
132 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2021.

Based on Select Equity Group's 13F filing for Q1 2021, filed 17 May 2021.